Johnson & Johnson's orthopaedics business in Australia, DePuy Synthes, has announced that the first clinical cases have been undertaken using its VELYS Robotic-Assisted Solution.
The VELYS Robotic-Assisted Solution is indicated for use with the ATTUNE Knee System for total knee arthroplasty.
Dr Matt Lyons, an orthopaedic surgeon at The Mater Hospital Sydney, said, “Our surgical team has been anticipating the arrival of the VELYS Robotic-Assisted Solution at the Mater since it first gained approval in Australia. Being able to plan patient-specific surgery tailored to each patient’s individual anatomy with the VELYS Robotic-Assisted Solution lets us visualise and predict joint stability to support optimal patient outcomes.”
Ben Travers, the vice president of DePuy Synthes Australia, said, “These cases represent a historic first step for patients as we advance next generation surgery with Australia’s first ever clinical use of the VELYS Robotic-Assisted Solution. The Mater Sydney’s adoption of our innovative surgical technology is only the beginning as we strive to improve patient outcomes through state-of-the-art digital surgery. We look forward to more patients benefiting from the VELYS Robotic-Assisted Solution in hospitals around Australia.”
DePuy Synthes said the use of the VELYS Robotic-Assisted Solution at the Mater Sydney is accompanied by the Johnson & Johnson Institute’s first-of-its-kind in Australia Mobile Training Lab.
The VELYS Mobile Lab provides on-site access to hands-on training, virtual reality-based operating environments, and real-time collaboration with the global surgical community.
Dr Lyons added, “Having access to the VELYS Mobile Lab nearby accelerated our training process significantly and enabled us to get our teams up and running on this new technology, quickly.”